Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

Hemolytic-uremic syndrome

A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury) The Plasma Large-Volume Exchange RCT Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS International Registry and Biorepository for TMA(Thrombotic Microangiopathy) Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients – ECULISHU Rituximab in Patients With Relapsed or Refractory TTP-HUS Usefulness of a Diagnostic Algorithm to Diagnose Thrombotic Microangiopathies in Pregnancy Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion Study of ‘Vascular Competence’ Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects Outcame of Cases With Hemolytic Uremic Syndrome Attending Assiut University Child Hospital Erythropoietin in Hemolytic Uremic Syndrome Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4